HMSA

Hitachi Medical Systems America (HMSA) has secured clearance from US Food and Drug Administration (FDA) for its Supria 16-slice CT system.

Featuring a compact design, the new system offers smart-dose compliant (XR-29) lower dose patient safety capabilities.

The system integrates the latest dose saving technologies in a compact design with improved access features to address a range of patient sizes, including bariatric patients.

The company noted the Supria 16-slice CT system can be placed in a scan room as small as 200ft².

"The dose reduction features included standard with Supria actually surpass the XR-29 standard."

Hitachi Medical Systems America CT marketing director Mark Silverman said: "Supria demonstrates Hitachi‘s continuing commitment to provide superior product value by combining the latest imaging technologies in a design that while compact, still affords the premium patient accommodation features of more expensive systems including a 75cm gantry aperture, standard 1.8m scannable range table with 500lb weight capacity."

HMSA is a wholly owned subsidiary of Hitachi Medical, which provides a wide range of diagnostic imaging equipment including MRI, CT and ultrasound.

Hitachi Medical Systems MR/CT vice-president Sheldon Schaffer said: "The Supria provides a strong value-based solution for CT providers needing to replace older higher-dose =16-slice CT systems with a new lower-dose smart dose compliant (XR-29) system.

"The dose reduction features included standard with Supria actually surpass the XR-29 standard."

Supria is equipped with the latest technologies for low dose imaging and excellent image quality. It also features new technologies for minimum dosage as standard.

In order to achieve low dose and high image quality, the system is equipped with the company’s latest noise reduction technology, iterative reconstruction processing (Intelli IP Advanced).


Image: Hitachi Supria CT system. Photo: courtesy of Business Wire.